Related Experiment Videos
The association between statin use and age related maculopathy
G McGwin1, C Owsley, C A Curcio
1Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL , USA. mcgwin@eyes.uab.edu
The British Journal of Ophthalmology
|August 21, 2003
Summary
This study found that individuals with age-related maculopathy (ARM) were less likely to have used statins. Further research is needed to confirm if statins can prevent or slow ARM progression.
Area of Science:
- Ophthalmology
- Cardiovascular Medicine
- Pharmacology
Background:
- Age-related maculopathy (ARM) is a leading cause of vision loss in older adults.
- Statins are widely used to lower cholesterol and reduce cardiovascular disease risk.
Purpose of the Study:
- To investigate the potential association between the use of statins and the incidence of age-related maculopathy (ARM).
Main Methods:
- A nested case-control study was conducted using data from the Veterans Affairs Medical Center.
- Newly diagnosed ARM cases were identified and matched with controls without ARM based on age.
Main Results:
- 550 cases of ARM and 5500 controls were analyzed.
- Patients with ARM were 70% less likely to have filled a statin prescription compared to controls.
- This protective association was observed for both current and past statin users, and for statin-only users and combined statin/non-statin users.
Conclusions:
- Findings suggest a significant inverse association between statin use and ARM.
- Clinical trials are recommended to establish the efficacy of statins in preventing or managing ARM.